Laparoscopy Combined with Enhanced Recovery Pathway in Ileocecal Resection for Crohn’s Disease: A Randomized Study

Abstract EN

Background and Aims.

Laparoscopic approach is recommended as the first-choice option for simple ileocecal resections.

However, there are no randomized trials that have focused on patients with Crohn’s disease (CD) treated by laparoscopy and enhanced recovery pathway.

The aim of the present study is to prospectively evaluate the feasibility, safety, and short-term outcomes of laparoscopy with enhanced recovery pathway for CD patients undergoing ileocecal resection.

Methods.

A consecutive cohort of 32 CD patients who underwent laparoscopic ileocecal resection between December 2015 and December 2016 was randomized to enhanced recovery after surgery (ERAS) group or standard care group.

Primary outcome was total postoperative hospital stay.

Secondary outcomes were time to first flatus and stool, pain scores, morbidity, reoperation rate, readmission rate, and in-hospital costs.

Results.

Compliance with the ERAS was high for all items (≥90%) except the items of abdominal drains and early fluid intake.

A significantly earlier return of bowel function was observed in the ERAS group.

Compared with the standard care group, patients in the ERAS group had shorter postoperative hospital stay and lower in-hospital costs (5.19 ± 1.28 versus 9.94 ± 3.33 days, P<0.001; 2.70 ± 0.50 versus 3.73 ± 0.75 ten thousand RMB, P<0.001, respectively).

Other parameters did not show any significant differences between the two groups.

Conclusions.

Laparoscopic approach within an ERAS perioperative care program is a safe and effective treatment combination for CD patients requiring ileocecal resection.

This study is registered at ClinicalTrials.gov (NCT02777034).